NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

組織型胞漿素原活性化因子市場 - 市場規模、佔有率、預測、機會分析:2021年∼2028年

Tissue Plasminogen Activator Market, By Drug Type, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版商 Coherent Market Insights 商品編碼 1009419
出版日期 內容資訊 英文 141 Pages
商品交期: 2-3個工作天內
價格
組織型胞漿素原活性化因子市場 - 市場規模、佔有率、預測、機會分析:2021年∼2028年 Tissue Plasminogen Activator Market, By Drug Type, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
出版日期: 2021年05月06日內容資訊: 英文 141 Pages
簡介

組織型胞漿素原活性化因子 (tPA) ,是血塊分解相關的酵素。缺血性中風的盛行率增加,預計促進在預測期間內的全球組織型胞漿素原活性化因子市場成長。本報告提供的見解將使市場行銷人員和公司的管理部門能夠就其未來的產品發布,類型升級,市場擴展和行銷策略做出明智的決定。

本報告提供全球組織型胞漿素原活性化因子市場相關調查分析,市場動態,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的、前提條件

第2章 市場範圍

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 流行病學
  • 主要的發展
  • 法規方案
  • PEST分析
  • 開發平台分析
  • 歷史概要

第4章 全球組織型胞漿素原活性化因子市場:COVID-19大流行的影響

  • COVID-19對醫療部門全體的影響
  • COVID-19流行病學
  • COVID-19對臨床試驗、醫藥品開發的影響

第5章 全球組織型胞漿素原活性化因子市場:各藥物類型

  • 簡介
  • Alteplase
  • Reteplase
  • Tenecteplase

第6章 全球組織型胞漿素原活性化因子市場:各適應症

  • 簡介
  • 缺血性中風
  • 心肌梗塞
  • 肺動脈栓塞
  • 血栓溶解
  • 其他

第7章 全球組織型胞漿素原活性化因子市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • F. Hoffmann-La Roche AG
    • Boehringer Ingelheim GmbH
    • CHIESI Farmaceutici SpA
    • Gennova Biopharmaceuticals Ltd
    • Abbott Laboratories
    • Reliance Life Sciences
  • 分析師的見解

第9章 Section

目錄

Tissue plasminogen activator (tPA) is an enzyme associated with the disintegration of blood clots. It is a serine protease present in endothelial cells. With the help of serine protease, the conversion of plasminogen to plasmin is catalyzed. Serine protease is a major enzyme for clot disintegration.

Market Dynamics

The increasing prevalence of ischemic strokes is expected to drive growth of the global tissue plasminogen activator market over the forecast period. For instance, Institute for Health Metrics and Evaluation report published in 2019, ischemia heart stroke accounted for around 63.5 million (95% UI 57*8-69*0) people globally. Ischemic stroke was responsible for 3.29 million (2*97-3*54) deaths in 2019 globally, with 3.45 million (2*96-4*03) incident cases in males and 4.19 million (3*61-4*91) in females.

Key features of the study:

  • This report provides in-depth analysis of the global tissue plasminogen activator market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue plasminogen activator market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd, Abbott Laboratories, and Reliance Life Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global tissue plasminogen activator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue plasminogen activator market

Detailed Segmentation:

  • Global Tissue Plasminogen Activator Market, By Drug Type:
  • Alteplase
  • Reteplase
  • Tenecteplase
  • Global Tissue Plasminogen Activator Market, By Application:
  • Ischemic Stroke
  • Myocardial Infarction
  • Pulmonary Embolism
  • Thrombolysis
  • Others
  • Global Tissue Plasminogen Activator Market, By Region:
  • North America
    • By Drug Type
    • Alteplase
    • Reteplase
    • Tenecteplase
    • By Application
    • Ischemic Stroke
    • Myocardial Infarction
    • Pulmonary Embolism
    • Thrombolysis
    • Others
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Drug Type
    • Alteplase
    • Reteplase
    • Tenecteplase
    • By Application
    • Ischemic Stroke
    • Myocardial Infarction
    • Pulmonary Embolism
    • Thrombolysis
    • Others
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Drug Type
    • Alteplase
    • Reteplase
    • Tenecteplase
    • By Application
    • Ischemic Stroke
    • Myocardial Infarction
    • Pulmonary Embolism
    • Thrombolysis
    • Others
    • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Drug Type
    • Alteplase
    • Reteplase
    • Tenecteplase
    • By Application
    • Ischemic Stroke
    • Myocardial Infarction
    • Pulmonary Embolism
    • Thrombolysis
    • Others
    • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Drug Type
    • Alteplase
    • Reteplase
    • Tenecteplase
    • By Application
    • Ischemic Stroke
    • Myocardial Infarction
    • Pulmonary Embolism
    • Thrombolysis
    • Others
    • By Country
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Drug Type
    • Alteplase
    • Reteplase
    • Tenecteplase
    • By Application
    • Ischemic Stroke
    • Myocardial Infarction
    • Pulmonary Embolism
    • Thrombolysis
    • Others
    • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • F. Hoffmann-La Roche AG *
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • CHIESI Farmaceutici S.p.A.
    • Gennova Biopharmaceuticals Ltd
    • Abbott Laboratories
    • Reliance Life Sciences

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trend
  • Epidemiology
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Pipeline Analysis
  • Historical Overview

4. Global Tissue Plasminogen Activator Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Impact on Overall Healthcare Sector
  • COVID-19 Epidemiology
  • COVID-19 Impact on Clinical Trials and Drug Development

5. Global Tissue Plasminogen Activator Market, By Drug Type, 2020 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Alteplase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Reteplase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Tenecteplase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)

6. Global Tissue Plasminogen Activator Market, By Application, 2020 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Ischemic Stroke
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Myocardial Infarction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Pulmonary Embolism
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Thrombolysis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)

7. Global Tissue Plasminogen Activator Market, By Region, 2020 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Drug Type, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Type, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Type, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Type, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Type, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2020 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • F. Hoffmann-La Roche AG *
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CHIESI Farmaceutici S.p.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gennova Biopharmaceuticals Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Reliance Life Sciences
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact